PSP Research LLC
CIK 2106939 · 在 SEC EDGAR 上查看 ↗
- 投资组合价值
- $187.9M
- 持仓
- 75
- 截至
- 2026年6月30日
按 13F 价值排名第 6650（共 9443） · 前 70.4%
投资组合价值同比（季度）：+32.9% 13F不披露现金
- 前十大持仓权重
- 88.03%
- 前二十五大持仓权重
- 92.09%
- 持仓高于 1%
- 2
- 有效持仓数量
- 2.7
仅基于13F多头股票持仓（现金、债券、空头未披露）
周转率 Q2 2026: 10.05% 估计买入 $47886212 · 卖出 $16542557
- 新仓位
- 11
- 增加
- 1
- 减少
- 30
- 已结清
- 15
本页内容
与标普500指数的表现对比
近似于基于季度SEC 13F快照构建的买入并持有投资组合。不包括现金、空头头寸、期权/衍生品和非13(f)证券——仅反映已披露的多头股票账簿，而非基金总资产管理规模。SEC文件延迟最多可达45天；这不是一个可实时复制的交易。
可定价覆盖率：99.7% · 已排除期权：0.0%
行业细分
Healthcare
14.0%
其他/未映射
86.0%
完整投资组合 75 持仓
| 类型 | 连胜 | 8个季度趋势 | |||||
|---|---|---|---|---|---|---|---|
| XBI XBI | $90202500 | 48.01% | 570000 | $53812223 | 上涨 ×1 | ||
| SGOV iShares 0-3 Month Treasury Bond ETF | $70469000 | 37.51% | 700000 | $7000 | |||
| RPRX Royalty Pharma plc - Class A Ordinary Shares | $616770 | 0.33% | 11000 | $89100 | |||
| NRIX Nurix Therapeutics, Inc. - Common stock | $606500 | 0.32% | 25000 | $161650 | 下跌 ×2 | ||
| INCY Incyte Corporation - Common Stock | $600808 | 0.32% | 5300 | $101972 | |||
| ARGX argenx SE - American Depositary Shares | $594701 | 0.32% | 641 | $126611 | |||
| IRON Disc Medicine, Inc. - Common Stock | $585120 | 0.31% | 8000 | $73600 | |||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $583380 | 0.31% | 14000 | $145320 | |||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $567630 | 0.30% | 17000 | $104635 | 下跌 ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $559500 | 0.30% | 30000 | $201600 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $556600 | 0.30% | 23000 | $96000 | 下跌 ×1 | ||
| TGTX TG Therapeutics, Inc. - Common Stock | $549400 | 0.29% | 10000 | $117540 | 下跌 ×2 | ||
| HALO Halozyme Therapeutics, Inc. - Common Stock | $547890 | 0.29% | 7000 | $29170 | 下跌 ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $539172 | 0.29% | 6800 | $28560 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $518700 | 0.28% | 15000 | $-46300 | 下跌 ×2 | ||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $516534 | 0.27% | 19700 | $52402 | |||
| AUPH Aurinia Pharmaceuticals Inc - Common Shares | $509100 | 0.27% | 30000 | $64500 | |||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $505605 | 0.27% | 3000 | $-1331 | 下跌 ×1 | ||
| IMVT Immunovant, Inc. - Common Stock | $500890 | 0.27% | 13000 | $23962 | 下跌 ×2 | ||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $500080 | 0.27% | 19766 | $60089 | |||
| PTCT PTC Therapeutics, Inc. - Common Stock | $489420 | 0.26% | 6000 | $80640 | |||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $483730 | 0.26% | 13000 | $71370 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $480727 | 0.26% | 15141 | $24226 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $470400 | 0.25% | 10000 | $-187320 | 下跌 ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $464400 | 0.25% | 12000 | $2520 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $458680 | 0.24% | 4000 | $-66047 | 下跌 ×2 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $444200 | 0.24% | 20000 | $81600 | |||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $441009 | 0.23% | 1465 | $-43716 | |||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $440580 | 0.23% | 7000 | $-50470 | |||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $437200 | 0.23% | 20000 | $-30000 | |||
| EXEL Exelixis, Inc. - Common Stock | $435280 | 0.23% | 8000 | $-77170 | 下跌 ×1 | ||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $411620 | 0.22% | 11000 | $12100 | |||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $406680 | 0.22% | 12000 | $-73470 | 下跌 ×1 | ||
| 未知发行人 (CUSIP: K08588103) | $400080 | 0.21% | 1500 | 上涨 ×1 | |||
| LQDA Liquidia Corporation - Common Stock | $398650 | 0.21% | 5000 | ||||
| STOK Stoke Therapeutics, Inc. - Common Stock | $392640 | 0.21% | 12000 | $1920 | |||
| VKTX Viking Therapeutics, Inc. - Common Stock | $390100 | 0.21% | 10000 | $-98000 | 下跌 ×1 | ||
| IMNM Immunome, Inc. - Common Stock | $381420 | 0.20% | 18000 | $-55980 | 下跌 ×2 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $367740 | 0.20% | 3000 | $51540 | |||
| HRMY Harmony Biosciences Holdings, Inc. - Common Stock | $364100 | 0.19% | 10000 | $-35967 | 下跌 ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $355250 | 0.19% | 7000 | $80850 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $355120 | 0.19% | 4000 | $94900 | 下跌 ×2 | ||
| NTLA Intellia Therapeutics, Inc. - Common Stock | $338400 | 0.18% | 20000 | $-6458 | 下跌 ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $322170 | 0.17% | 600 | $8088 | |||
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $319750 | 0.17% | 5000 | $-113600 | 下跌 ×2 | ||
| ALKS Alkermes plc - Ordinary Shares | $314370 | 0.17% | 6000 | $102210 | |||
| TNGX Tango Therapeutics, Inc. - Common Stock | $312600 | 0.17% | 10000 | $11352 | 下跌 ×1 | ||
| ARDX Ardelyx, Inc. - Common Stock | $306000 | 0.16% | 60000 | $-173200 | 下跌 ×1 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $300370 | 0.16% | 7000 | $-101930 | 下跌 ×1 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $292675 | 0.16% | 2500 | $-169225 | 下跌 ×2 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $285510 | 0.15% | 3000 | $41830 | 下跌 ×1 | ||
| SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $279060 | 0.15% | 6000 | $-31080 | |||
| CRSP CRISPR Therapeutics AG - Common Shares | $272700 | 0.15% | 5000 | $-179215 | 下跌 ×2 | ||
| ZYME Zymeworks Inc. - Common Stock | $261400 | 0.14% | 10000 | $11000 | |||
| KRYS Krystal Biotech, Inc. - Common Stock | $257196 | 0.14% | 692 | 上涨 ×1 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $254700 | 0.14% | 18000 | $-137930 | 下跌 ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $253512 | 0.13% | 4200 | $9282 | |||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $244770 | 0.13% | 1000 | $-236092 | 下跌 ×1 | ||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $244604 | 0.13% | 7041 | 上涨 ×1 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $243700 | 0.13% | 2500 | $-175900 | 下跌 ×2 | ||
| JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | $233982 | 0.12% | 971 | ||||
| KOD Kodiak Sciences Inc - Common Stock | $233760 | 0.12% | 6000 | $-147440 | 下跌 ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $224736 | 0.12% | 1200 | ||||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $223440 | 0.12% | 3000 | $-222120 | 下跌 ×2 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $222060 | 0.12% | 2000 | ||||
| DNLI Denali Therapeutics Inc. - Common Stock | $217668 | 0.12% | 8463 | ||||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $211926 | 0.11% | 2600 | ||||
| SRRK Scholar Rock Holding Corporation - Common Stock | $210485 | 0.11% | 3827 | 上涨 ×1 | |||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $203150 | 0.11% | 5000 | $-1600 | 下跌 ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $194650 | 0.10% | 10838 | $44002 | |||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $147750 | 0.08% | 39400 | 上涨 ×1 | |||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $147300 | 0.08% | 15000 | $20250 | |||
| EYPT EyePoint, Inc. - Common Stock | $143000 | 0.08% | 10000 | $14100 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $140790 | 0.07% | 13000 | $-23920 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $125100 | 0.07% | 10000 | $-24000 | |||
| 无匹配项 | |||||||
最大新仓位
本季度新开仓位，按规模从大到小排序。
季度涨幅榜
已退出持仓
包含公司事件（合并、退市）——并非所有退出都是卖出
已关闭的头寸反映了 13F 报告的变更；对于指数管理人来说，这些通常是机械性的（退市、并购、指数再平衡），而不是主动决策。
| 证券 | 季度 | 先前持股数 | 先前价值 | 退出后价格 |
|---|---|---|---|---|
| SERA | 2026年6月30日 | 2396685 | $4865271 | 9.3% |
| TYRA | 2026年6月30日 | 16000 | $612800 | -18.9% |
| TVTX | 2026年3月31日 | 15272 | $583543 | 118.2% |
| ASND | 2026年6月30日 | 2500 | $571825 | -2.8% |
| JAZZ | 2026年3月31日 | 3258 | $553860 | 32.9% |
| CGON | 2026年3月31日 | 13293 | $551925 | 16.6% |
| BLTE | 2026年3月31日 | 3443 | $550742 | 6.3% |
| APLS | 2026年3月31日 | 21866 | $549274 | 不再跟踪 |
| TERN | 2026年3月31日 | 13560 | $547824 | 不再跟踪 |
| RVMD | 2026年3月31日 | 6872 | $547355 | 116.0% |
| CNTA | 2026年3月31日 | 21879 | $547194 | 不再跟踪 |
| CYTK | 2026年6月30日 | 8300 | $547053 | -10.1% |
| MLYS | 2026年3月31日 | 14818 | $537745 | -3.3% |
| ACLX | 2026年3月31日 | 8224 | $536205 | 不再跟踪 |
| ROIV | 2026年3月31日 | 24621 | $534276 | 33.7% |
| LQDA | 2026年3月31日 | 15485 | $534078 | 93.2% |
| PVLA | 2026年3月31日 | 5084 | $532142 | 15.7% |
| INSM | 2026年3月31日 | 3049 | $530648 | -21.5% |
| NUVL | 2026年3月31日 | 5261 | $529204 | 不再跟踪 |
| VRDN | 2026年3月31日 | 16967 | $528013 | 23.5% |
| WVE | 2026年3月31日 | 31040 | $527680 | -26.3% |
| MAZE | 2026年3月31日 | 12672 | $525001 | -0.6% |
| DNLI | 2026年3月31日 | 31762 | $524391 | 30.9% |
| BMRN | 2026年3月31日 | 8772 | $521320 | 20.7% |
| BEAM | 2026年3月31日 | 18334 | $508218 | 15.6% |
| AGIO | 2026年6月30日 | 15000 | $507450 | -8.1% |
| RYTM | 2026年3月31日 | 4738 | $507156 | 29.9% |
| PRAX | 2026年6月30日 | 1500 | $483285 | 13.2% |
| UPB | 2026年3月31日 | 17634 | $478763 | -19.0% |
| GPCR | 2026年3月31日 | 6719 | $467306 | 10.5% |
| MNMD | 2026年3月31日 | 34841 | $466521 | 不再跟踪 |
| INBX | 2026年6月30日 | 6927 | $465702 | 4.5% |
| ARWR | 2026年3月31日 | 6689 | $444083 | 39.2% |
| ALMS | 2026年3月31日 | 43769 | $427185 | 7.3% |
| ERAS | 2026年6月30日 | 17327 | $280351 | -4.4% |
| CELC | 2026年6月30日 | 2000 | $228280 | -12.1% |
| KALV | 2026年6月30日 | 10795 | $217303 | 不再跟踪 |
| LEGN | 2026年6月30日 | 12000 | $217080 | -22.4% |
| APGE | 2026年6月30日 | 2500 | $210425 | 1.5% |
| UTHR | 2026年6月30日 | 350 | $207543 | -3.2% |
| SMMT | 2026年6月30日 | 10223 | $193828 | -13.7% |
| CMPX | 2026年6月30日 | 30000 | $158700 | 11.9% |